BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Laurus Labs Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
540222
ISIN Demat
INE947Q01028
Book Value (Rs)
97.214696
NSE Symbol
LAURUSLABS
Divident Yield %
0.12
Market Cap
(Rs In Cr.)
92,612
P/E (TTM)
106.15
EPS (TTM)
16.15
Face Value
(Rs)
2
Back
Laurus Labs consolidated net profit rises 125.49% in the June 2026 quarter
24-Jul-26   Hrs IST

Net profit of Laurus Labs rose 125.49% to Rs 367.60 crore in the quarter ended June 2026 as against Rs 163.02 crore during the previous quarter ended June 2025. Sales rose 29.10% to Rs 2026.31 crore in the quarter ended June 2026 as against Rs 1569.57 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales2026.311569.57 29
OPM %31.5024.35 -
PBDT605.23341.06 77
PBT481.36224.22 115
NP367.60163.02 125

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)